--- title: Periodontics & Gum Disease Treatment at Smile Solutions Melbourne: The Complete Guide to Specialist Periodontist Care canonical_url: https://directory.smilesolutions.com.au/dental-health-specialist-care/periodontics-gum-disease-treatment/periodontics-gum-disease-treatment-at-smile-solutions-melbourne-the-complete-guide-to-specialist-periodontist-care/ category: description: geography: city: state: country: metadata: phone: email: website: publishedAt: --- # Periodontics & Gum Disease Treatment at Smile Solutions Melbourne: The Complete Guide to Specialist Periodontist Care ## Executive Summary Periodontal disease is one of the most consequential and most underestimated chronic conditions in Australian healthcare. In Australia, 30% of adults aged 15 years and over had moderate or severe periodontitis in 2017–18 - a figure that represents an increase from around one-quarter (23%) in 2004–06. Yet the majority of those affected have no idea the disease is destroying the bone and tissue anchoring their teeth, because periodontitis is, by its biological nature, minimises discomfort until the damage is irreversible. This pillar page is the definitive resource on periodontics and gum disease treatment at Smile Solutions Melbourne. It synthesises the full body of specialist knowledge across every dimension of the discipline: what the periodontium is and how it fails; why some patients are catastrophically susceptible while others with identical oral hygiene remain unaffected; how periodontitis silently connects to heart disease, diabetes, and premature birth; what specialist periodontists do that general dentists cannot; and how every treatment modality - from non-surgical debridement to laser-assisted regeneration, from soft tissue grafting to peri-implantitis management - fits into a coherent, evidence-based care pathway. What makes Smile Solutions uniquely positioned to deliver this care is not simply the presence of board-registered specialist periodontists, but the integration of those specialists within Australia's largest single-location private dental practice - a multidisciplinary environment where periodontists, prosthodontists, oral surgeons, and orthodontists collaborate under one roof, without referral delays, without fragmented records, and without the clinical handover failures that too often compromise complex periodontal outcomes. If you have been told you have gum disease, or if you suspect you might, this is the resource to read first. --- ## What Is Periodontics? The Specialty, the Science, and the Stakes ### Defining the Field Periodontics is the dental specialty concerned with the prevention, diagnosis, and treatment of diseases affecting the periodontium - the complex of structures that surround, support, and anchor your teeth in the jaw. The word derives from the Greek *peri* ("around") and *odont* ("tooth"). It is a field of medicine, not merely dentistry, and its clinical consequences extend far beyond the mouth. The periodontium consists of four principal structures: the gingiva (gums), the alveolar bone (the portion of the jaw that forms and supports tooth sockets), the periodontal ligament (the connective tissue fibres that attach teeth to bone), and cementum (the outer layer of the tooth root). These structures do not function independently - they operate as a single integrated unit, each one dependent on the others for structural integrity. When one component is compromised by infection or inflammation, the others follow. What distinguishes periodontal disease from dental caries is the nature and extent of the destruction. Periodontitis causes damage that extends to the surrounding soft and hard tissues - causing not only aesthetic and masticatory impairment, but also anatomical deformities due to severe alveolar bone resorption that increase the complexity of any subsequent dental rehabilitation. Critically, that bone, once lost, does not regenerate without specialist intervention. ### The Australian Burden: A Rising Epidemic The scale of periodontal disease in Australia demands that it be treated as a genuine public health crisis. The overall prevalence of moderate or severe periodontitis among the Australian dentate population was 30.1%, and in contrast to gingivitis, the prevalence of moderate or severe periodontitis significantly increased with age - almost 70% of dentate adults aged 75 years and over experienced periodontitis. Some three in every ten Australian adults had moderate to severe periodontitis, and there was a tendency of higher prevalence of periodontitis in NSAOH 2017–18 than in NSAOH 2004–06 among people of the same age. This is not a stable public health picture - it is a worsening one. The Australian health system spent $898 million on periodontal disease in a recent reporting period, and overall, $12.5 billion was spent on dental services in 2022–23, up from $9.8 billion in 2012–13. Globally, the worldwide estimated direct treatment costs and productivity losses due to periodontitis (including periodontitis-related tooth loss) amounted to US$186 billion and US$142 billion in 2019, respectively. These figures are not abstract. They represent the downstream cost of a disease that, when intercepted early by a specialist periodontist, is arrestable - and when left untreated, produces a cascade of tooth loss, implant complications, and systemic disease burden that costs vastly more to manage. *(For a detailed explanation of the periodontium's anatomy, the disease spectrum from gingivitis through Stage IV periodontitis, and the 2018 AAP/EFP staging and grading framework, see our guide on [What Is Periodontics? The Complete Guide to Gum Disease, the Periodontium, and Specialist Care].)* --- ## The Silent Disease: Recognising Gum Disease Before It's Too Late ### Why Periodontitis Goes Undetected The central clinical paradox of periodontal disease is that the biological mechanism destroying your jaw bone simultaneously suppresses the pain signals that would otherwise alert you to the damage. The bacterial enzymes and toxins responsible for this destruction are simultaneously inhibiting the pro-algesic effects of inflammatory mediators - meaning the inflammation is real and progressive, but it does not hurt in the way a toothache does. The consequence is stark: most patients who receive a diagnosis of chronic periodontitis do so not because they felt pain, but because they were told by a clinician that they had the disease. Only a small minority - approximately 6.2% in one study - reported having painful gingiva as their chief complaint. Most had already lost significant bone before the diagnosis was made. ### The Symptom Progression: From Gingivitis to Stage IV The symptom profile of periodontal disease follows the disease's staging - but with a critical lag. Symptoms that patients notice (tooth mobility, drifting, visible recession) appear only after the underlying structural damage is already advanced. **Gingivitis (Reversible):** Bleeding gums during brushing or flossing is the single most important early warning sign. Healthy gums do not bleed. Redness, puffiness, and soft tissue texture changes indicate gingival inflammation - but no bone has yet been lost, and the condition is fully reversible with professional cleaning and improved home care. **Early to Moderate Periodontitis (Stages I–II):** Periodontal pockets form below the gum line - invisible to the patient, detectable only by a calibrated periodontal probe. Persistent bad breath (halitosis) from volatile sulphur compounds produced by anaerobic bacteria in oxygen-depleted pockets is a frequently dismissed but clinically significant symptom. Gum recession begins, making teeth appear longer. **Severe Periodontitis (Stage III):** Radiographic bone loss becomes clinically significant. Tooth mobility appears - the first symptom that typically drives patients to seek care. Pathological tooth drifting and spacing changes occur as the periodontal ligament fibres that maintain tooth position are destroyed. Suppuration (pus) may be visible. **Advanced Periodontitis (Stage IV):** Masticatory dysfunction, bite collapse, spontaneous pain from periodontal abscesses, and tooth loss. In 2017–18, older Australians aged 65 and over had an average of 13.7 missing teeth. Most (59%) suffered periodontitis and around one-quarter (27%) avoided eating some foods due to problems with their teeth, mouth or dentures. ### The Smoking Masking Effect: A Critical Diagnostic Complication One of the most clinically dangerous intersections of risk factors and symptom recognition is tobacco smoking. Nicotine causes vasoconstriction in gingival tissues, suppressing bleeding on probing - the primary early warning sign. A smoker may present with severe underlying bone destruction while appearing clinically reassuring because their gums do not bleed. This is why specialist-level clinical assessment, including radiographic bone-level measurement, is essential for all smokers - not just those with visible symptoms. *(For a complete stage-by-stage symptom breakdown, including the masking effect of smoking on clinical presentation, see our guide on [Gum Disease Symptoms: How to Recognise the Early and Advanced Warning Signs of Periodontitis].)* --- ## Why Some People Are Far More Susceptible: The Causes and Risk Factors of Periodontitis ### Bacteria Are Necessary But Not Sufficient The most important insight in modern periodontics is that bacterial plaque is a *necessary* cause of periodontitis, but not a *sufficient* one. The landmark Sri Lankan tea worker study by Loë et al. demonstrated this definitively: despite universal plaque accumulation and no professional dental care over 15 years, only 8% of subjects showed rapid attachment loss, 81% showed moderate loss, and 11% showed no attachment loss at all. The same bacterial challenge produced three entirely different disease trajectories - which means the host's biological response is the decisive variable. This insight reframes periodontitis as a disease of *host susceptibility* as much as bacterial infection - and it has profound implications for treatment planning. ### Smoking: The Dominant Modifiable Risk Factor Tobacco smoking carries the most extensively documented evidence base of any modifiable risk factor. A landmark analysis of NHANES III data found an adjusted odds ratio of 3.97 between smoking and periodontitis, with a clear dose-dependent relationship - and estimated that 74.8% of periodontitis cases were attributable to smoking. Among subjects aged 31–40, the prevalence of periodontitis was 88% in current smokers compared to 33% in never-smokers. The mechanism is not simply one of poor hygiene. Smoking primarily increases immunosuppression in periodontal pockets - suppressing the immune surveillance that would otherwise contain infection. This explains why smokers often present with deeper pockets but *less* clinical bleeding - a deceptively reassuring sign that masks severe underlying destruction. ### Diabetes: A Bidirectional Amplifier Periodontitis is independently associated with cardiovascular diseases, diabetes, chronic obstructive pulmonary disease, obstructive sleep apnoea, and COVID-19 complications. The relationship between periodontitis and diabetes is the most thoroughly evidenced systemic link in periodontics, operating in both directions simultaneously. Type 2 diabetes enhances the risk of developing periodontitis by 34%, while severe periodontitis increases type 2 diabetes incidence by 53%. For patients who carry both risk factors - poorly controlled diabetes and tobacco use - the combined effect is synergistic. A 2024 longitudinal cohort study found that individuals with diabetes had a 3.1 times higher odds ratio for developing periodontitis, rising to 4.8 times when tobacco use was also present. A systematic review addressing the impact of periodontal treatment on HbA1c levels demonstrated a mean reduction of 0.36% at 3 months, with data from four systematic reviews with meta-analyses providing consistent evidence that successful periodontal therapy results in a clinically meaningful and statistically significant reduction of HbA1c levels in people with type 2 diabetes, ranging from 0.27% to 0.48% at 3–4 months following periodontal therapy. This is a finding of direct clinical significance: treating gum disease can meaningfully contribute to glycaemic control - not as a replacement for medical management, but as a legitimate complementary intervention. ### Genetic Susceptibility: Up to Half of Risk Is Inherited Heritability estimates for periodontal bone loss range between 0.4 and 0.5 - meaning that up to half of an individual's susceptibility to bone-destructive periodontitis is genetically determined, a figure comparable to the heritability of type 2 diabetes. The genetic architecture centres primarily on immune-regulatory genes, including variants in the interleukin-1 (IL-1) gene cluster that have been confirmed as statistically significant risk factors in multiple meta-analyses. Genetic susceptibility is non-modifiable - but identifying it allows Smile Solutions' specialist periodontists to calibrate the intensity of monitoring and the frequency of maintenance appointments accordingly. ### Medications, Age, and Hormonal Influences Several classes of commonly prescribed medications directly affect periodontal risk. Drug-induced gingival overgrowth (DIGO) affects an estimated 50% of adults treated with phenytoin, 30% with cyclosporin, and 20% with nifedipine. Antidepressants, antihistamines, and antihypertensives that cause xerostomia (dry mouth) reduce salivary buffering and accelerate disease progression. Bisphosphonates used in osteoporosis and cancer management are associated with medication-related osteonecrosis of the jaw (MRONJ), which complicates surgical periodontal treatment. The prevalence of periodontitis among participants was lowest in those with higher education and highest in those who had Year 10 or less of schooling (45%). Males, individuals without a degree or higher qualification, those who were eligible for public dental care, those not dentally insured, and those who usually visited a dentist for a dental problem experienced significantly greater periodontitis levels than their counterparts. *(For a detailed examination of all risk factors - including the synergistic interaction between smoking and diabetes, the genetics of immune-regulatory polymorphisms, and the full medication risk profile - see our guide on [Gum Disease Causes and Risk Factors: Why Some People Are More Susceptible to Periodontitis].)* --- ## Periodontics and Systemic Health: The Body-Wide Consequences of Untreated Gum Disease ### Beyond the Mouth: A Systemic Inflammatory Disease The most important paradigm shift in modern periodontics is the recognition that periodontitis is not a localised oral infection - it is a chronic inflammatory non-communicable disease (NCD) with body-wide consequences. Three overlapping pathways explain how a gum infection becomes a systemic threat: bacteraemia (periodontal pathogens entering the bloodstream through inflamed gingival tissue), systemic inflammation (elevated C-reactive protein and inflammatory cytokines that disrupt cell signalling), and shared genetic susceptibility between periodontal disease and systemic conditions. A 2024 umbrella review of 41 systematic reviews continued to affirm a significant association between periodontal disease and CVD and suggested dysbiotic oral bacteria and systemic inflammatory responses as primary mechanisms. ### Cardiovascular Disease Periodontitis is independently associated with cardiovascular diseases, diabetes, chronic obstructive pulmonary disease, obstructive sleep apnoea, and COVID-19 complications. A systematic review found that periodontal disease is likely to cause a 19% increase in the risk of cardiovascular disease, and this increase in relative risk reaches 44% among individuals aged 65 years and over. Periodontitis has also been implicated in conditions like chronic obstructive pulmonary disease, pneumonia, rheumatoid arthritis, chronic kidney disease, and Alzheimer's, largely due to its role in systemic inflammation and potential microbial translocation. The biological mechanism is well-characterised. Periodontal pathogens - particularly *Porphyromonas gingivalis* - have been detected in atheromatous plaque samples and vascular walls, where they may contribute to the progression of atherosclerosis and a procoagulant response. Cross-reactive autoantibodies against bacterial antigens, particularly those against heat shock proteins, promote atherosclerotic changes through subsequent autoimmune responses in the vascular endothelium. Evidence from interventional trials strengthens this relationship: systematic reviews consistently show significant reduction in C-reactive protein (CRP) levels following various types of periodontal treatment. Given that elevated CRP is one of the most reliable independent predictors of cardiovascular events, this finding has direct clinical relevance for patients managing cardiac risk. ### Diabetes: The Sixth Complication Periodontal disease is now classified by many researchers as the sixth complication of diabetes - not a dental side-effect, but a co-morbid NCD that must be managed in parallel with medical care. Type 2 diabetic individuals with severe forms of periodontal disease have 3.2 times greater mortality risk compared with individuals with no or mild periodontitis. The mechanism runs through shared inflammatory pathways: chronic hyperglycaemia contributes to the dysregulation of immune responses and exacerbates periodontal tissue destruction, while periodontitis itself impairs glycaemic control by sustaining systemic inflammation and interfering with insulin signalling pathways through elevated TNF-α, IL-1β, and IL-6. ### Pregnancy Outcomes Periodontal disease occurs in approximately 40% of pregnant women. The association between maternal periodontitis and adverse pregnancy outcomes - including preterm birth, low birth weight, and pre-eclampsia - has been studied for nearly three decades. A 2024 meta-analysis found a moderate-to-strong association between periodontitis and low birth weight (OR 2.48; 95% CI 1.72–3.59), strengthening further in case-control analyses (OR 3.94; 95% CI 1.95–7.96). The proposed mechanisms include haematogenous spread of periodontal bacteria to the uteroplacental unit, elevation of prostaglandin E2 and interleukin-1β (the same mediators that trigger uterine contractions), and systemic cytokine load compromising placental function and fetal growth. ### The Clinical Imperative of Integration Oral health care professionals and family doctors should collaborate in managing these conditions. Closer collaboration between oral health care professionals and family doctors is important in the early case detection and management of NCDs like cardiovascular diseases, diabetes mellitus, and respiratory diseases. This is precisely the model that Smile Solutions' multidisciplinary structure enables - not through formal medical collaboration alone, but by ensuring that specialist periodontists who understand the systemic dimensions of their patients' disease are the ones delivering care. *(For a deep-dive into the peer-reviewed evidence on the cardiovascular, diabetic, and pregnancy associations, including the HbA1c intervention data and the Mendelian randomisation evidence for causal stroke risk, see our guide on [Gum Disease and Systemic Health: The Evidence Linking Periodontitis to Heart Disease, Diabetes, and Pregnancy Outcomes].)* --- ## Specialist Periodontist vs. General Dentist: Understanding the Clinical and Regulatory Difference ### A Legally Protected Title With Statutory Requirements In Australia, the title "periodontist" is a legally protected specialist designation under the National Registration and Accreditation Scheme administered by AHPRA and the Dental Board of Australia. There are 13 dental specialties approved by the Australian Health Workforce Ministerial Council - periodontics is one of them, and using the title without specialist registration is unlawful. To achieve specialist registration in periodontics, a dentist must complete their primary dental degree (4–5 years), at least two years of general dental practice, and then a three-to-four-year full-time postgraduate specialist training program - typically a Doctor of Clinical Dentistry (Periodontics) at the University of Sydney, the University of Queensland, or the University of Adelaide. These programs require a substantial research dissertation alongside intensive clinical training, producing graduates who are not just technically proficient but who can critically evaluate emerging evidence and apply it to complex patient presentations. In total, a board-registered specialist periodontist has completed a minimum of nine to eleven years of tertiary-level education and supervised clinical training before holding their specialist title. ### What Specialists Can Do That General Dentists Cannot | Clinical Domain | General Dentist | Specialist Periodontist | |---|---|---| | Gingivitis management | ✅ | ✅ | | Early periodontitis (SRP) | ✅ | ✅ | | Moderate–severe periodontitis | Limited | ✅ Full spectrum | | Periodontal flap/osseous surgery | Generally not performed | ✅ | | Guided tissue regeneration | Generally not performed | ✅ | | Soft tissue grafting (SCTG, FGG, PST) | Generally not performed | ✅ | | Peri-implantitis management | Limited | ✅ | | Crown lengthening surgery | Limited | ✅ | | Laser-assisted periodontal therapy | Limited | ✅ Advanced applications | | Specialist registration (AHPRA) | ❌ | ✅ | The critical distinction for patients is not that general dentists cannot treat gum disease - they can and do manage gingivitis and early periodontitis effectively. The distinction is that moderate-to-severe periodontitis, cases requiring surgical intervention, peri-implantitis, and complex soft tissue management require the depth of knowledge and clinical experience that only specialist-level training provides. Advanced CPD-based training completed by general dentists, while valuable, does not constitute specialist registration and does not confer the right to use the protected title "periodontist." Patients can and should verify any practitioner's specialist registration status directly on the AHPRA online register before undergoing complex periodontal treatment. *(For a detailed side-by-side analysis of training pathways, scope of practice, and the specific clinical presentations that warrant specialist referral, see our guide on [Periodontist vs. General Dentist: What's the Difference and When Do You Need a Specialist?].)* --- ## Your First Specialist Periodontal Consultation at Smile Solutions ### What the Appointment Actually Involves For most patients, the greatest source of anxiety about their first periodontist appointment is not knowing what will happen. The initial specialist consultation at Smile Solutions is a structured, multi-stage diagnostic process - not a treatment session. Understanding its components removes that uncertainty. **Stage 1 - Medical History and Interview:** The consultation begins with a systematic review of chief complaint, dental history, medical history (including medications, systemic diseases, and smoking status), and social history. This is not administrative box-ticking - it directly informs clinical interpretation. A patient with moderate attachment loss and poorly controlled Type II diabetes, for example, will have their disease graded at a higher progression risk than the clinical measurements alone would suggest. **Stage 2 - Extra-Oral and Intra-Oral Examination:** A systematic clinical examination of the head, neck, and oral cavity, including lymph node palpation, temporomandibular joint assessment, mucosal examination, occlusal assessment, and visual inspection of all teeth. **Stage 3 - Full-Mouth Periodontal Charting:** The diagnostic centrepiece of the consultation. Using a calibrated periodontal probe, the specialist records pocket depths at six sites per tooth across the entire dentition, bleeding on probing (BOP), clinical attachment loss (CAL), furcation involvement in multi-rooted teeth, and tooth mobility. This data cannot be abbreviated without compromising diagnostic accuracy. The clinical significance of pocket depth measurements is profound: a landmark 10-year longitudinal study demonstrated that probing depth severity translates, in a dose-dependent manner, to follow-up tooth loss even after many years. **Stage 4 - Radiographic Bone-Level Assessment:** Periapical radiographs using the long cone paralleling technique provide the most accurate representation of the height of the bone in relation to the cementoenamel junction. The specialist assesses the pattern of bone loss (horizontal vs. angular/vertical defects), extent as a percentage of root length, distribution (localised vs. generalised), furcation radiolucency, and existing restorations. **Stage 5 - Clinical Photography:** Standardised intraoral and extraoral photographs are taken as a visual baseline, for patient education, and as part of the medicolegal clinical record. **Stage 6 - Periodontal Diagnosis:** The specialist integrates all clinical and radiographic findings to arrive at a formal diagnosis using the 2018 AAP/EFP staging and grading framework - determining both the *severity* of disease at presentation (Stages I–IV) and the *rate of likely progression* (Grades A–C). This dual framework is what enables truly personalised treatment planning. *(For a step-by-step account of every instrument, every measurement, and what the numbers mean for your treatment, see our guide on [Your First Periodontist Appointment at Smile Solutions: What to Expect at a Specialist Periodontal Consultation].)* --- ## The Treatment Pathway: From Non-Surgical Therapy to Regenerative Surgery ### Phase 1: Non-Surgical Debridement - The Gold Standard First Line For the majority of patients presenting with periodontitis - from Stage I through Stage III - the first line of clinical intervention is non-surgical: full-mouth debridement, subgingival scaling and root planing (SRP) under local anaesthetic, adjunctive antimicrobial therapy where indicated, and structured oral hygiene re-education. Root planing is superior in terms of clinical attachment level gain when pocket depth is 4–6 mm, and periodontal surgery is superior when pocket depth is greater than 6 mm. This evidence-based threshold is the decision logic that governs the non-surgical/surgical boundary at Smile Solutions. At Smile Solutions, SRP is delivered by board-registered specialist periodontists using a combination of ultrasonic scalers and hand instruments (curettes), under local anaesthetic, either on a quadrant-by-quadrant basis or as full-mouth therapy within a compressed timeframe. The treating periodontist selects the delivery protocol based on disease severity, patient systemic health, and anatomical complexity. Adjunctive antimicrobial therapy - locally delivered chlorhexidine, or systemic antibiotics in selected patients with Grade C disease or poorly controlled diabetes - is not applied routinely to every patient. The specialist makes an evidence-informed decision based on disease staging and grading, residual pocket depths, and specific risk factors. A 2024 randomised clinical trial published in the *International Journal of Dental Hygiene* found that twice-daily powered toothbrushing sustained the effects of SRP for bleeding on probing, probing pocket depth, and plaque significantly better than manual toothbrushing in Stage I/II periodontitis patients, with differences persisting for 24 weeks. Three months after non-surgical therapy, the specialist reassesses pocket depths, BOP, and clinical attachment levels. This reassessment determines whether disease has been arrested - or whether surgical intervention is warranted. *(For a detailed explanation of each procedure, what patients experience during and after treatment, and the evidence base for adjunctive antimicrobials, see our guide on [Non-Surgical Gum Disease Treatment: How Scaling, Root Planing, and Debridement Work at Smile Solutions].)* ### Phase 2: Periodontal Surgery - When Non-Surgical Therapy Reaches Its Limits When residual pockets of ≥5–6 mm persist with bleeding on probing after thorough non-surgical debridement - particularly where angular bone defects, furcation involvement, or complex root anatomy obstruct adequate instrumentation access - surgery becomes the evidence-supported next step. A systematic review and meta-analysis found that 12 months following treatment, surgical therapy resulted in 0.6 mm more probing pocket depth reduction and 0.2 mm more clinical attachment level gain than non-surgical therapy in deep pockets greater than 6 mm. Smile Solutions' specialist periodontists plan and perform the full spectrum of periodontal surgical procedures: **Open-Flap Debridement (OFD):** A full-thickness mucoperiosteal flap is reflected to provide direct visualisation and access for thorough root surface instrumentation. A systematic review and meta-analysis of 27 trials found a tooth survival rate of 98% at 12 months, with clinical attachment level gain of 1.65 mm and probing depth reduction of 2.80 mm. **Osseous Surgery (Resective Pocket Reduction):** Where bone defects have created irregular, negative architecture - interproximal craters, ledges, and uneven crestal bone levels - osseous surgery adds bone recontouring to the access flap procedure, achieving physiologic architecture that is maintainable long-term. Apically positioned flap surgery with osseous recontouring is more effective than without osseous recontouring in reducing periodontal pocket depth and levels of major periodontal pathogens. **Guided Tissue Regeneration (GTR) and Bone Grafting:** For deep intrabony defects - particularly angular defects with three walls of remaining bone - regenerative surgery aims to rebuild the lost periodontium rather than simply reduce pockets. A biocompatible barrier membrane selectively blocks faster-growing epithelial cells, creating space for bone and ligament cells to repopulate the defect. A systematic review of 79 randomised controlled trials found that all regenerative procedures provided adjunctive clinical attachment level gain of 1.34 mm compared with open flap debridement alone, with both enamel matrix derivative (EMD) and GTR superior to OFD alone. *(For a complete guide to surgical indications, the step-by-step procedural sequence, recovery timelines, and the microbiological evidence for osseous surgery's effect on periodontal pathogens, see our guide on [Periodontal Surgery at Smile Solutions: A Guide to Flap Surgery, Osseous Surgery, and Surgical Pocket Reduction].)* ### Gum Grafting for Receding Gums Gum recession affects approximately 50% of adults over 30 and carries consequences beyond aesthetics - exposed root surfaces are at elevated risk of hypersensitivity, root caries, cervical abrasion, and progressive attachment loss. Soft tissue grafting is the definitive treatment for moderate-to-severe recession. Smile Solutions' specialist periodontists select from a range of evidence-based grafting techniques based on each patient's recession pattern, gingival biotype, causal factors, and aesthetic goals: - **Subepithelial Connective Tissue Graft (SCTG) + Coronally Advanced Flap:** The gold standard for root coverage, achieving average root coverage rates of 98% in long-term follow-up in experienced hands. The dual blood supply from both the underlying connective tissue bed and the overlying recipient flap is the biological mechanism behind this superior outcome. A 20-year RCT confirmed significantly better relative root coverage than guided tissue regeneration at both 3 and 120 months. - **Free Gingival Graft (FGG):** Specifically indicated when the primary need is to increase the width of attached, keratinised gingiva rather than cover roots - particularly in non-aesthetic zones or for pre-implant soft tissue augmentation. A long-term split-mouth study found that teeth receiving FGG had approximately 1.5 mm reduction in recession, while contralateral untreated sites experienced an increase of 0.7–1.0 mm over the same timeframe. - **Pinhole Surgical Technique (PST):** A minimally invasive alternative that eliminates the need for donor tissue, sutures, and incisions - using a needle-sized entry point and specialised instruments to reposition gingival tissue coronally. Patients experience immediate aesthetic improvements with minimal postoperative discomfort. *(For a detailed comparison of all grafting techniques, causal factor assessment, and the evidence base for long-term root coverage stability, see our guide on [Gum Grafting for Receding Gums: Connective Tissue Grafts, Free Gingival Grafts, and the Pinhole Technique Explained].)* ### Laser Periodontal Therapy Dental lasers at Smile Solutions are deployed as both adjunctive tools in non-surgical therapy and as primary instruments in specific surgical protocols. The clinical versatility of laser systems derives from selective absorption: different tissues contain different chromophores that absorb specific wavelengths, enabling precise tissue interaction without collateral thermal damage. **Diode lasers (810–980 nm):** Used for sulcular debridement, gingival contouring, and bacterial reduction within periodontal pockets. Their haemostatic properties enhance visibility and reduce postoperative bleeding. **Nd:YAG lasers (1,064 nm):** Deep tissue penetration enables debridement of infected tissue in advanced pockets. The LANAP (Laser-Assisted New Attachment Procedure) protocol - an FDA-cleared, minimally invasive surgical approach - uses the Nd:YAG laser to selectively remove diseased pocket epithelium and create a stable fibrin clot for tissue re-attachment, without sutures or exogenous materials. A retrospective case series found that 93.5% of probing depth measurements were ≤3 mm at 12–18 month re-evaluation, with 54% of eligible sites gaining at least 2 mm of clinical attachment. **Er:YAG lasers (2,940 nm):** The only laser system that can be effectively and safely used in both soft and hard tissues with minimal thermal side effects. Its high water absorption minimises thermal influence on surrounding tissues, making it uniquely suited to root surface debridement, bone surgery, and implant site preparation. *(For a full technical comparison of laser types, the LANAP protocol step-by-step, and the evidence for laser-assisted sulcular debridement as an adjunct to SRP, see our guide on [Laser Periodontal Treatment at Smile Solutions].)* ### Crown Lengthening and Gum Lifts Crown lengthening is one of the most clinically versatile procedures in a specialist periodontist's repertoire, serving both functional and aesthetic indications. **Restorative Crown Lengthening:** When a tooth is too broken down, too decayed, or fractured at or below the gum line to be properly restored, crown lengthening surgically exposes additional tooth structure by repositioning the gingival margin and, where necessary, the underlying bone. The foundational concept is the supracrestal tissue attachment (STA) - a zone of biological attachment averaging 2.04 mm that must not be invaded by a dental restoration. When restorative margins encroach on the STA, chronic inflammation, bone loss, and periodontitis result. **Aesthetic Crown Lengthening (Gummy Smile Correction):** Altered passive eruption (APE) - where the gingival margin fails to migrate apically to its correct position during tooth eruption - is the most common cause of excessive gingival display amenable to surgical correction. A normal smile displays 1–2 mm of gingival tissue; greater than 4 mm is considered excessive gingival display. The psychosocial impact of a gummy smile is well-documented: excessive gingival display negatively affects perceived attractiveness, and also how friendly, trustworthy, intelligent, and self-confident a person is perceived to be. At Smile Solutions, crown lengthening is planned collaboratively between the specialist periodontist and the on-site prosthodontist - ensuring the surgical endpoint is defined by the restorative or aesthetic requirement before a single incision is made. *(For a detailed explanation of the biological width, the three surgical techniques, presurgical assessment protocols, and recovery timelines, see our guide on [Crown Lengthening and Gum Lifts at Smile Solutions].)* --- ## Peri-Implantitis: When Gum Disease Attacks Dental Implants ### A Growing and Underestimated Crisis Dental implants are one of modern dentistry's most transformative achievements - but they are not immune to infection. The weighted mean prevalence of peri-implant mucositis was 63.0% at the patient level and 59.2% at the implant level. Peri-implantitis was observed in 25.0% of patients and 18.0% of implants. Prevalence rates at the patient level for peri-implant mucositis and peri-implantitis were 46% and 21%, respectively. Weighted mean incidence rates at the patient level for peri-implant mucositis and peri-implantitis were 53% and 22%, respectively, within 20 years of function. These are not minor inconveniences. Left untreated, peri-implantitis destroys the bone holding an implant in place - more rapidly and less predictably than equivalent disease around natural teeth. ### Why Peri-Implantitis Is Harder to Treat Than Periodontitis The implant surface presents a fundamentally different biological environment from a natural tooth root. Modern implants are deliberately manufactured with roughened, micro-textured surfaces to promote osseointegration - the same surface architecture that creates an ideal substrate for bacterial biofilm accumulation and makes complete decontamination extraordinarily difficult. Furthermore, around natural teeth, the body has a structural defence mechanism that partially contains the infection. Around an implant, that containment mechanism is absent, and bone destruction can proceed directly and rapidly. Two associations - the presence of periodontitis (OR = 3.84 [95% CI 2.58–5.72]) and cigarette smoking (RR = 2.07 [95% CI 1.41–3.04]) - were graded as highly suggestive risk factors for peri-implantitis. For peri-implantitis, the significant risk indicators were periodontitis, diabetes mellitus, smoking habits, and alcohol consumption. This is why patients who have previously been treated for gum disease require specialist-level monitoring of their implants, not routine dental check-ups alone. ### The Treatment Protocol Peri-implant mucositis - the reversible precursor stage - may be effectively managed with non-surgical debridement and risk factor control, using implant-compatible instruments (non-metallic ultrasonic tips, resin or carbon fibre curettes) to avoid damaging the implant surface. Established peri-implantitis with significant bone loss typically requires surgical intervention. Three primary surgical approaches are available: access surgery (open-flap debridement for direct visualisation and decontamination), resective surgery with implantoplasty (mechanical smoothing of the exposed implant surface to reduce bacterial adhesion), and reconstructive surgery (bone grafting to regenerate lost peri-implant bone in contained defects). *(For a complete guide to peri-implant disease diagnosis, the staged treatment protocol, implantoplasty, and the evidence for surgical vs. non-surgical approaches, see our guide on [Peri-Implantitis Treatment: What to Do When Gum Disease Develops Around Dental Implants].)* --- ## Supportive Periodontal Therapy: The Phase That Protects Everything Else ### Why Periodontics Is a Treatment, Not a Cure One of the most critical concepts in periodontal medicine is that completing active treatment - whether non-surgical debridement, surgical pocket reduction, or regenerative procedures - achieves disease *arrest*, not disease *cure*. Periodontitis is a chronic, biofilm-driven inflammatory condition that, once established, never fully disappears. The bacteria responsible, the genetic susceptibility, and the structural changes left in the periodontium all remain after treatment ends. Supportive Periodontal Therapy (SPT) is the phase on which the entire investment of active treatment depends. The evidence is unambiguous: patients who maintain regular SPT retain more teeth, experience less disease progression, and sustain better long-term periodontal stability than those who do not. ### Individualised Risk-Based Recall Intervals The modern evidence-based standard is not a single fixed recall interval for all patients - it is individualised, risk-stratified recall. The Periodontal Risk Assessment (PRA) tool, developed by Lang and Tonetti, integrates six key factors: smoking, diabetes, bleeding on probing, residual teeth, bone loss, and systemic conditions. A comparative study found that patients attending three-month intervals had the lowest incidence of disease recurrence (8%), while those on six-month intervals experienced 12% recurrence rates, and annual intervals resulted in 20% recurrence. In patients affected by moderate to advanced periodontitis, a supportive periodontal therapy protocol based on a 2–4 month recall interval appears reasonable. At Smile Solutions, recall intervals are calculated from each patient's clinical data and reassessed at every SPT appointment, adjusted as risk profiles change. ### What a Maintenance Appointment Includes A periodontal maintenance visit is fundamentally different from a standard dental scale-and-clean. It includes: medical and dental history update; full periodontal re-charting with comparison to previous recordings; radiographic monitoring at appropriate intervals; plaque and oral hygiene assessment; professional supragingival and subgingival debridement; periodontal risk reassessment; and escalation decision-making where new or progressive sites are identified. ### Home Care: The Evidence on Interdental Cleaning The 2019 Cochrane systematic review (Worthington et al.), analysing 35 randomised controlled trials involving 3,929 participants, found that additional use of floss or interdental brushes compared to toothbrushing alone may reduce gingivitis or plaque, or both - and that interdental brushes may be more effective than floss. One of the consensus findings from the EFP 2015 workshop states that "cleaning with interdental brushes is the most effective method for interproximal plaque removal." This is particularly relevant for periodontitis patients, who commonly have widened embrasures that make interdental brushes more effective than string floss. *(For a complete guide to recall interval determination, the SPT appointment protocol, and the evidence base for home-care adjuncts, see our guide on [Periodontal Maintenance: How to Prevent Gum Disease from Returning After Specialist Treatment].)* --- ## The Cost of Specialist Periodontal Treatment in Melbourne ### The Financial Case for Early Intervention Despite its largely preventable nature, periodontitis is highly prevalent worldwide and imposes a substantial health and economic burden on individuals and society as a whole. The worldwide estimated direct treatment costs and productivity losses due to periodontitis (including periodontitis-related tooth loss) amounted to US$186 billion and US$142 billion in 2019, respectively. At the individual level, the financial equation is equally stark: treating early-stage periodontal disease costs a fraction of managing the bone loss, tooth loss, and implant rehabilitation that results from leaving it untreated. A recent report by The Economist Intelligence Unit examined the cost-effectiveness of interventions to prevent and manage periodontal diseases, suggesting that prevention of periodontitis through prevention of gingivitis by means of individual home care would be more cost-efficient than four other examined approaches. ### What Specialist Periodontal Treatment Costs in Melbourne The fees involved with periodontal and peri-implant therapy vary widely depending on the patient's needs, disease severity, number of teeth affected, and type of treatment performed. | Treatment Phase | Typical Melbourne Range | Key ADA Item Numbers | |---|---|---| | Specialist consultation (incl. charting + X-rays) | $250–$350 | 011, 022, 221 | | Non-surgical therapy (per quadrant) | $300–$500+ | 222, 250 | | Full-mouth non-surgical therapy | $1,500–$3,000 | 222 × 4–8, 250, 251 | | Periodontal flap/osseous surgery (per quadrant) | $800–$2,500+ | 311, 321, 322 | | Gum grafting (per tooth) | $500–$800+ | 415, 416 | | Regenerative procedures (GTR, bone grafting) | $1,500–$2,500+ per site | 323, 324 | | Periodontal maintenance visit | $180–$350 | 114, 222, 251 | *Note: Fees are indicative ranges for Melbourne specialist practices and will vary based on clinical complexity. A detailed itemised quote with ADA item numbers is provided following your initial consultation at Smile Solutions.* ### Private Health Insurance and HICAPS Medicare does not cover periodontal treatment in private practice. Periodontal treatment is generally classified under **Major Dental** in Australian private health insurance Extras policies, which typically carry 12-month waiting periods. Rebates typically range from 50% to 75% of the fee, with some funds offering up to 100% ("no gap") for selected procedures. Patients with specialist periodontists generally receive higher rebates than those treated by general dentists under health fund benefit schedules. Smile Solutions uses HICAPS for on-the-spot rebate processing - meaning patients pay only the gap amount at the time of service, rather than claiming reimbursement after the fact. *(For a detailed breakdown of ADA item numbers, how to maximise annual insurance limits across calendar years, and strategies for managing cost across a multi-phase treatment plan, see our guide on [Cost of Periodontal Treatment in Melbourne: What to Expect and How Private Health Insurance and Payment Plans Apply].)* --- ## Why Choose Smile Solutions for Specialist Periodontal Care ### Board-Registered Specialist Periodontists: Non-Negotiable At Smile Solutions, all periodontal treatment is carried out by Dental Board of Australia–registered specialist periodontists. This is not a marketing claim - it is a verifiable regulatory fact. Every patient can confirm specialist registration status on the AHPRA online register before their first appointment. This matters because the rising prevalence of periodontitis in Australia - 30% of adults aged 15 years and over in 2017–18, up from 23% in 2004–06 - is occurring in a healthcare environment where most patients receive their initial gum care from general dentists who have not completed the postgraduate training required for specialist registration. The consequence is that many patients with moderate-to-severe disease are managed sub-optimally at the general dentistry level until the disease has progressed to a point where specialist intervention is unavoidable - and where the irreversible bone loss already sustained cannot be recovered. Choosing a board-registered specialist periodontist from the outset compresses this timeline and increases the probability of halting disease before structural damage is permanent. ### The Multidisciplinary Advantage: One Building, All Specialists Periodontitis is almost never a standalone clinical problem. Patients with advanced gum disease frequently present with missing teeth, compromised restorations, occlusal issues, or aesthetic concerns that require coordinated treatment across multiple dental specialties. The clinical evidence supports this reality: in practice, to improve the treatment success of advanced periodontitis, a multidisciplinary approach involving orthodontics, prosthodontics, and endodontics is required. At Smile Solutions, this coordination is structural, not aspirational. The practice's registered specialists include oral and maxillofacial surgeons, orthodontists, prosthodontists, periodontists, endodontists, and paediatric specialists - all caring for patients in one location. The specialist periodontists work closely with the practice's prosthodontists in cases requiring restorative treatments such as crowns, bridges, implants, or combinations of these. When a periodontist and prosthodontist co-manage a complex case - for example, a patient requiring crown lengthening before a crown can be placed, or peri-implantitis treatment followed by implant restoration - the communication is immediate, the treatment plan is shared, and the patient does not face the delays, miscommunications, or coordination failures that occur when specialists are at different practices. ### No Referral Required: Direct Access to Specialist Care Many patients assume they must first see a general dentist, obtain a referral, and wait for a specialist appointment. At Smile Solutions, patients can self-refer directly to a specialist periodontist. This removes a meaningful logistical barrier and accelerates access to the level of care the disease actually requires - particularly important given that delay in a disease causing irreversible bone loss has permanent consequences. ### Scale, Technology, and Location Located in the iconic Manchester Unity Building at Collins and Swanston Streets in Melbourne's CBD, Smile Solutions is Australia's largest single-location private dental practice. Scale enables capabilities that smaller practices cannot sustain: advanced hard and soft tissue laser systems for laser-assisted periodontal therapy and LANAP; an in-house laboratory using only TGA-approved materials; a team of over 20 registered specialists, 40+ general dentists, and 23 dental hygienists and therapists; and a CBD location directly accessible by tram and train from across metropolitan Melbourne. For periodontal patients who require maintenance appointments every three to four months for life, the convenience of a genuinely accessible, fully integrated specialist practice is not a minor consideration - it is a factor in long-term treatment compliance and, therefore, long-term disease stability. *(For a detailed breakdown of the Smile Solutions clinical model, the multidisciplinary team structure, and how in-house collaboration changes outcomes for complex cases, see our guide on [Why Choose Smile Solutions for Periodontal Treatment].)* --- ## Frequently Asked Questions **Q: What is the difference between gingivitis and periodontitis?** Gingivitis is reversible inflammation of the gums caused by bacterial plaque accumulation. It produces redness, swelling, and bleeding, but causes no permanent damage to the bone or attachment apparatus. Periodontitis is the progression of gingivitis into the supporting structures - destroying the periodontal ligament and alveolar bone in ways that cannot be reversed without specialist intervention. The critical distinction is irreversibility: once bone is lost to periodontitis, it does not grow back without regenerative treatment. **Q: Can gum disease really affect my heart and diabetes?** Yes - and the evidence is substantial. Periodontitis is independently associated with cardiovascular diseases, diabetes, chronic obstructive pulmonary disease, obstructive sleep apnoea, and COVID-19 complications. The relationship with diabetes is bidirectional: diabetes worsens periodontitis, and periodontitis impairs glycaemic control. Data from four systematic reviews with meta-analyses have provided consistent evidence that successful periodontal therapy results in a clinically meaningful and statistically significant reduction of HbA1c levels in people with type 2 diabetes, ranging from 0.27% to 0.48% at 3–4 months following periodontal therapy. **Q: Do I need a referral to see a board-registered specialist periodontist at Smile Solutions?** No. Patients can book directly with a board-registered specialist periodontist at Smile Solutions without a referral from a general dentist or GP. Direct access removes a logistical barrier that too often delays treatment in a condition where delay produces irreversible consequences. **Q: How do I know if a dentist is actually a registered specialist periodontist?** Under Australian law, the title "periodontist" is legally protected and can only be used by practitioners registered with AHPRA in the specialty of periodontics. You can verify any practitioner's specialist registration status directly on the AHPRA online register at ahpra.gov.au. All periodontists at Smile Solutions hold Dental Board of Australia specialist registration. **Q: How many appointments does periodontal treatment take?** This depends entirely on disease severity and staging. A patient with Stage I–II periodontitis may require two to four non-surgical debridement appointments followed by a three-month reassessment. A patient with Stage III–IV disease may require non-surgical therapy across multiple sessions, a surgical phase, and then lifelong supportive periodontal therapy every two to four months. Your specialist periodontist will outline the full treatment timeline at your initial consultation. **Q: Can gum disease come back after treatment?** Yes - and this is why supportive periodontal therapy (SPT) is not optional. Periodontitis is a chronic condition; the bacterial biofilm that drives it reforms daily. Without professional disruption of that biofilm at regular intervals, and without monitoring for early signs of recurrence, disease can re-establish. Research shows that patients on three-month recall intervals have an 8% recurrence rate, compared to 20% for those on annual intervals. **Q: Is periodontal surgery painful?** Surgical procedures are performed under local anaesthetic, so patients experience pressure and vibration rather than pain during the procedure itself. Postoperative discomfort - swelling, sensitivity, and mild aching - is managed with prescribed analgesics and typically peaks at days two to three before resolving progressively. Guided regeneration procedures require longer healing periods than simple access surgery, but most patients return to normal function within one to two weeks. **Q: How does peri-implantitis differ from gum disease around natural teeth?** Peri-implantitis is the implant equivalent of periodontitis - a bacterial infection destroying the bone around a dental implant - but it is harder to treat and progresses more rapidly. Approximately two in three adults with dental implants had peri-implant mucositis, and one in four had peri-implantitis. The roughened implant surface that promotes osseointegration also harbours bacterial biofilm that is extremely difficult to decontaminate completely, and the soft tissue seal around an implant is inherently less resistant to bacterial invasion than around a natural tooth root. Specialist periodontist involvement is essential for accurate diagnosis and management. --- ## Key Takeaways 1. **Periodontal disease is Australia's most prevalent chronic inflammatory disease.** 30% of Australian adults aged 15 and over had moderate or severe periodontitis in 2017–18 - and the prevalence is rising, not falling. Most of those affected are unaware. 2. **The disease is largely silent until irreversible.** The biological mechanism of periodontitis simultaneously suppresses the pain signals that would otherwise alert patients to the destruction occurring in their jaw bone. Specialist-level diagnosis - with full-mouth periodontal charting and radiographic bone-level assessment - is the only reliable way to detect the disease before permanent damage is done. 3. **Susceptibility is not just about oral hygiene.** Genetic predisposition, tobacco smoking, diabetes, medications, and hormonal factors all substantially modify individual susceptibility. Two patients with identical oral hygiene can have radically different disease trajectories - which is why risk-stratified treatment planning by a specialist periodontist is essential. 4. **Periodontitis is a systemic disease.** The evidence linking it to cardiovascular disease, diabetes, adverse pregnancy outcomes, COPD, and other non-communicable diseases is now the consensus of the world's leading periodontal and medical bodies. Treating gum disease is not just about saving teeth - it is a meaningful contribution to whole-body health. 5. **Specialist registration matters.** The title "periodontist" is legally protected in Australia. Board-registered specialist periodontists have completed nine to eleven years of tertiary education and are the appropriate providers for moderate-to-severe periodontitis, surgical intervention, peri-implantitis, and complex soft tissue management. 6. **The treatment pathway is sequential and evidence-based.** Non-surgical SRP is the gold standard first line. Surgery is reserved for cases where non-surgical therapy does not achieve adequate pocket reduction. Regenerative procedures aim to rebuild what disease has destroyed. And supportive periodontal therapy, delivered for life at risk-stratified intervals, is the phase that protects everything else. 7. **Peri-implantitis is a growing crisis.** More than half of the patients treated with dental implants were affected by peri-implant diseases over a 10-year follow-up period. Patients with a history of periodontitis face nearly five times the implant-level risk of peri-implantitis compared to those without. Specialist monitoring of implants is not optional for these patients. 8. **Multidisciplinary care under one roof changes outcomes.** The integration of specialist periodontists with prosthodontists, oral surgeons, and other specialists at Smile Solutions is not a logistical convenience - it is a clinical advantage that enables the coordinated treatment planning that complex periodontal cases require. --- ## Conclusion: The Window of Opportunity Is Now Periodontal disease does not announce itself with pain. It destroys quietly, progressively, and largely invisibly - until the bone loss is clinically significant, the teeth are mobile, and the options are substantially narrowed. Periodontal and peri-implant diseases result from a chronic inflammatory response to dysbiotic microbial communities and are characterised by inflammation in the soft tissue and the ensuing progressive destruction of supporting bone, resulting in tooth or implant loss. These diseases' high prevalence, multifactorial etiology, extensive treatment costs, and significant detriment to patients' quality of life underscore their status as a critical public health burden. The good news is that periodontal disease, intercepted by a specialist periodontist before it reaches advanced stages, is arrestable. The bone loss already sustained cannot be recovered without regenerative intervention - but further destruction can be stopped. Gum recession can be corrected. Implants at risk can be stabilised. And the systemic health consequences of chronic periodontal inflammation can be meaningfully reduced. The window of opportunity is always now - before the next pocket deepens, before the next millimetre of bone is lost, before the next tooth becomes non-restorable. Smile Solutions' board-registered specialist periodontists are available without a referral, in Melbourne's CBD, within a multidisciplinary team that can manage every dimension of your periodontal and restorative care in a single, integrated environment. If you have not had a specialist periodontal assessment - and particularly if you smoke, have diabetes, have a family history of gum disease, or have been told by a general dentist that you have "some bone loss" - the most important next step is a comprehensive specialist consultation. --- Smile Solutions has been providing specialist periodontal care from Melbourne's CBD since 1993. Located at the Manchester Unity Building, Level 12 and Tower, 220 Collins Street, Smile Solutions brings together 60+ clinicians - including 25+ board-registered specialists - who have cared for over 250,000 patients. No referral is required to book a specialist appointment. Call **13 13 96** or visit smilesolutions.com.au to arrange your specialist periodontal consultation. ## References - Australian Institute of Health and Welfare (AIHW). "National Oral Health Plan 2015–2024: Performance Monitoring Report." *AIHW*, 2020. https://www.aihw.gov.au/reports/dental-oral-health/national-oral-health-plan-2015-2024 - Ha DH, Spencer AJ, Ju X, Do LG. "Periodontal Diseases in the Australian Adult Population." *Australian Dental Journal*, 2020. https://doi.org/10.1111/adj.12765 - Herrera D, Sanz M, Shapira L, et al. "Periodontal Diseases and Cardiovascular Diseases, Diabetes, and Respiratory Diseases: Summary of the Consensus Report by the European Federation of Periodontology and WONCA Europe." *European Journal of General Practice*, 2024;30(1):2320120. https://doi.org/10.1080/13814788.2024.2320120 - Galarraga-Vinueza ME, Pagni S, Finkelman M, Schoenbaum T, Chambrone L. "Prevalence, Incidence, Systemic, Behavioral, and Patient-Related Risk Factors and Indicators for Peri-Implant Diseases: An AO/AAP Systematic Review and Meta-Analysis." *Journal of Periodontology*, 2025;96(6):587–633. https://doi.org/10.1002/JPER.24-0154 - Pattamatta M, et al. "The Value-for-Money of Preventing and Managing Periodontitis: Opportunities and Challenges." *Periodontology 2000*, 2024. https://doi.org/10.1111/prd.12569 - Diaz P, Gonzalo E, Gil Villagra LJ, Miegimolle B, Suarez MJ. "What Is the Prevalence of Peri-Implantitis? A Systematic Review and Meta-Analysis." *BMC Oral Health*, 2022;22:449. https://doi.org/10.1186/s12903-022-02493-8 - Botelho J, Machado V, Leira Y, Proença L, Chambrone L, Mendes JJ. "Economic Burden of Periodontitis in the United States and Europe: An Updated Estimation." *Journal of Periodontology*, 2022;93(3):373–379. https://doi.org/10.1002/JPER.21-0111 - Australian Institute of Health and Welfare (AIHW). "Oral Health and Dental Care in Australia: Disease Expenditure." *AIHW*, 2024. https://www.aihw.gov.au/reports/dental-oral-health/oral-health-and-dental-care-in-australia/contents/disease-expenditure - Worthington HV, MacDonald L, Poklepovic Pericic T, et al. "Home Use of Interdental Cleaning Devices, in Addition to Toothbrushing, for Preventing and Controlling Periodontal Diseases and Dental Caries." *Cochrane Database of Systematic Reviews*, 2019. - Tonetti MS, Greenwell H, Kornman KS. "Staging and Grading of Periodontitis: Framework and Proposal of a New Classification and Case Definition." *Journal of Periodontology*, 2018;89(Suppl 1):S159–S172. https://doi.org/10.1002/JPER.18-0006